Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 3Gynecologic 2Endocrine 2Thoracic 1NET 1Head & Neck 1Gastrointestinal 1CNS 1Breast 1

Conditions

Neuroendocrine Tumors 11Adrenocortical Carcinoma 7Thyroid Carcinoma, Anaplastic 5Carcinoma, Neuroendocrine 4Thyroid Neoplasms 3Adrenal Cortex Neoplasms 3Ovarian Neoplasms 2Neoplasm Metastasis 2Carcinoma, Small Cell 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Vulvar Neoplasms 1Vascular Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Thyroid cancer, Hurthle cell 1Thyroid Cancer, Papillary 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Pheochromocytoma 1Penile Neoplasms 1Pathologic Processes 1Parotid Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Paraganglioma 1Neoplasms, Unknown Primary 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1

Interventions

pembrolizumab 2Etoposide 2Cisplatin 2veliparib 1taxane 1liposomal doxorubicin 1Vinorelbine 1RRx-001 1Quality of Life 1Podophyllotoxin 1Platinum 1Pemetrexed 1Patient Reported Outcome Measures 1Paclitaxel 1PT-100 dipeptide 1Nivolumab 1Molecular Diagnostic Techniques 1Irinotecan 1Ipilimumab 1Immunotherapy 1Gemcitabine 1Drug Therapy 1Carboplatin 1Biological Therapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Small Cell × pembrolizumab × Endocrine × Clear all
NCT03910660 2026-05-15

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

BioXcel Therapeutics Inc

Phase 1/2 Completed
98 enrolled
EndocrineGenitourinaryNET

Prostatic Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT02721732 2026-01-29

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
157 enrolled 26 charts
CNSEndocrineGenitourinary

Adrenal Cortex Neoplasms, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms, Unknown Primary, Paraganglioma, Penile Neoplasms, Pheochromocytoma, Carcinoma, Small Cell, Vascular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡